Imidazoline receptor binding compounds
US6635668B1 · kind B1 · utility
Assignee
Inventors
Key dates
| Filing date | Jul 22, 1998 |
| Grant date | Oct 21, 2003 |
| Priority date | — |
| Expiry date | Jul 22, 2018 |
Classification
- Technology area (CPC G)Physics
- CPC primaryG01N2500/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Pentamidine and analogs thereof have activity as imidazoline receptor binding compounds. A method of binding the imidazoline receptor, comprises contacting a bis-benzene to said imidazoline receptor in an amount effective to bind to said receptor, wherein said bis-benzene contains at least one amidine group (e.g., one or two). The contacting step may be carried out in vivo or in vitro. Contacting may be carried out with individual active compounds or with libraries of active compounds.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.